On August 2, 2013, an amended protocol for our upcoming study of MDMA-assisted therapy for social anxiety in autistic adults was submitted to the Institutional Review Board at Harbor-UCLA/Los Angeles Biomedical …
On July 8, 2013, the U.S. Food and Drug Administration fully approved the amended protocol for our planned study of MDMA-assisted therapy for social anxiety in adults on the autism spectrum, to be led …
On April 23, 2012, we learned that the U.S. Drug Enforcement Administration had approved the application for a Schedule I MDMA distributor’s license by a contract research firm specializing in synthetic, …
On September 14, 2011, the Drug Enforcement Administration (DEA) notified MAPS that it had approved the Schedule 1 licenses required to transport, store, and administer the MDMA for our new “relapse …
On April 22, the first subject was treated in our training study for MDMA-assisted psychotherapy researchers. The protocol was designed as a Phase 1 study of the psychological effects of MDMA administered …
On March 22-24, 2011, MAPS Lead Clinical Research Associate Berra Yazar-Klosinski, Ph.D., and MAPS Clinical Research Intern Katie Hendy, M.A., and MAPS Director of Finance and IT Josh Sonstroem (who is …
An article from the U.K. National Health Service (NHS) adeptly summarizes the purpose, methods, and results of Dr. John H. Halpern’s latest study of the risks of Ecstasy. which showed no evidence …
On Nov. 26, 2010, three days after MAPS’ clinical research submitted the amendment for our Vancouver study of MDMA-assisted psychotherapy for PTSD, it was approved by the Canadian Institutional Review …
On October 8, a conference call was held between our Canadian pharmacist, Colin Holyk of Kerrisdale Pharmacy, Vancouver, and MAPS’ clinical research staff. The team planned our continuing negotiations …
Canadian MDMA/PTSD Study Gains Institutional Affiliation On July 19, 2010, Health Canada informed principal investigator Ingrid Pacey, M.D. that they would accept a letter from the director of the University …
Canadian MDMA Import Under Review Mark Kozlowski, Acting Manager of the Licenses and Permits Division of the Office of Controlled Substances at Health Canada informed Ingrid Pacey, M.D. that his office …
Over 100 Media Articles Related to Journal of Psychopharmacology Publication There were at least 138 media articles about the publication of MAPS' U.S. MDMA-assisted psychotherapy study for the treatment …
